PlainRecalls
FDA Drug Moderate Class II Terminated

TRI MIX 40/30/4 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/4mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Reported: May 24, 2017 Initiated: April 18, 2017 #D-0748-2017

Product Description

TRI MIX 40/30/4 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/4mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Details

Units Affected
5 vials
Distribution
Distributed nationwide in U.S.A., Australia and Canada.
Location
Federal Way, WA

Frequently Asked Questions

What product was recalled?
TRI MIX 40/30/4 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/4mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy. Recalled by Key Pharmacy and Compounding Center. Units affected: 5 vials.
Why was this product recalled?
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 24, 2017. Severity: Moderate. Recall number: D-0748-2017.